Targeting Pyruvate Kinase M2 As a Novel Therapeutic Strategy Against Liver Fibrosis and Hepatocellular Carcinoma

被引：0

作者：

Zheng, Dandan ^{[1
]}

Lin, Zelong ^{[1
,2
]}

Hu, Kaishun ^{[3
]}

Lan, Tian ^{[4
]}

Holmes, Jacinta A. ^{[5
,6
,7
]}

Song, Zhenghui ^{[2
,8
]}

He, Lu ^{[1
]}

Jiang, Yuchuan ^{[1
]}

Chen, Peng ^{[1
,2
]}

Tu, Mengxian ^{[1
]}

Chen, Hengxing ^{[3
]}

Hu, Qiaoting ^{[1
]}

Qu, Chen ^{[1
,2
]}

Lin, Wenyu ^{[5
,6
,7
]}

Li, Aimin ^{[2
,8
]}

Chung, Raymond T. ^{[5
,6
,7
]}

Hong, Jian ^{[1
,2
]}

机构：

[1] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Abdominal Surg, Guangzhou, Guangdong, Peoples R China

[2] Southern Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China

[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China

[4] Guangdong Pharmaceut Univ, Guangzhou, Guangdong, Peoples R China

[5] Massachusetts Gen Hosp, Liver Ctr, Boston, MA 02114 USA

[6] Massachusetts Gen Hosp, Gastrointestinal Div, Boston, MA 02114 USA

[7] Harvard Med Sch, Boston, MA USA

[8] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Dept Hepatol, Guangzhou, Guangdong, Peoples R China

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1120

引用

页码：646A / 647A

页数：2

共 50 条

[31] Targeting CCL2/CCR2 signallingas a therapeutic strategy against hepatocellular carcinoma
Science Foundation in China, 2016, (01) : 39 - 39
[32] Characterization of Pyruvate Kinase M2 in the Retina
Rajala, Raju V. S.
Rajala, Ammaji
Wang, Yuhong
Anderson, Robert E.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[33] UPREGULATION OF ISOENZYME M2 OF PYRUVATE KINASE IN BLADDER CANCER: IMPLICATION IN TUMOR INITIATION, PROGRESSION AND THERAPEUTIC TARGETING.
Zhou, Haiping
Huang, Kuo-How
Liu, Yan
He, Feng
Wang, Xing
Mo, Lan
Lepor, Herbert
Tang, Moon-shong
Huang, Chuanshu
Wu, Xue-Ru
JOURNAL OF UROLOGY, 2015, 193 (04): : E543 - E543
[34] LOCALISATION OF THE GLYCOLYTIC ISOZYME, PYRUVATE KINASE M2 IN THE LUNG OF IDIOPATHIC PULMONARY FIBROSIS
Tan, S.
Forty, E. J.
Durrenberger, P. F.
McAnulty, R. J.
Chambers, R. C.
Mercer, P. F.
THORAX, 2017, 72 : A109 - A110
[35] M2 Form of Pyruvate Kinase in Stiffness Induced Myofibroblast Differentiation in Lung Fibrosis
Che, P.
Ding, Q.
Wang, Y.
Cai, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[36] TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma
Chen, Z.
Wang, Z.
Guo, W.
Zhang, Z.
Zhao, F.
Zhao, Y.
Jia, D.
Ding, J.
Wang, H.
Yao, M.
He, X.
ONCOGENE, 2015, 34 (30) : 3946 - 3956
[37] TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma
Z Chen
Z Wang
W Guo
Z Zhang
F Zhao
Y Zhao
D Jia
J Ding
H Wang
M Yao
X He
Oncogene, 2015, 34 : 3946 - 3956
[38] Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma
Hu, Wen
Lu, Shi-Xun
Li, Min
Zhang, Chao
Liu, Li-Li
Fu, Jia
Jin, Jie-Tian
Luo, Rong-Zhen
Zhang, Chris Zhiyi
Yun, Jing-Ping
ONCOTARGET, 2015, 6 (09) : 6570 - 6583
[39] Targeting cyclin dependent kinase 5 in hepatocellular carcinoma - A novel therapeutic approach
Ehrlich, Sandra M.
Liebl, Johanna
Ardelt, Maximilian A.
Lehr, Thorsten
De Toni, Enrico N.
Mayr, Doris
Brandl, Lydia
Kirchner, Thomas
Zahler, Stefan
Gerbes, Alexander L.
Vollmar, Angelika M.
JOURNAL OF HEPATOLOGY, 2015, 63 (01) : 102 - 113
[40] Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
Schnabl, Alyssa
Ellmeier, Elena
Stracke, Anika
Seifried, Katharina
Tafrali, Cansu
Demjaha, Rina
Wurth, Sebastian
Khalil, Michael
Angiari, Stefano
EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 74 - 74

← 1 2 3 4 5 →